ArticleCrohn's & colitis 3602023

Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn's Disease: Post Hoc Analyses of VISIBLE Studies.

William J Sandborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.